Holen Sie sich die Stockscreener-App
221.03
0.06%
0.14
Schlusskurs vom Vortag:
$220.89
Offen:
$220.85
24-Stunden-Volumen:
1.42M
Relative Volume:
1.07
Marktkapitalisierung:
$6.95B
Einnahmen:
$302.00K
Nettoeinkommen (Verlust:
$-117.10M
KGV:
-19.86
EPS:
-11.13
Netto-Cashflow:
$-129.13M
1W Leistung:
+0.10%
1M Leistung:
+0.52%
6M Leistung:
+361.73%
1J Leistung:
+709.63%
1-Tages-Spanne:
$220.47
$221.10
1-Wochen-Bereich:
$220.40
$221.10
52-Wochen-Spanne:
$15.22
$221.20
Cidara Therapeutics Inc Stock (CDTX) Company Profile
Firmenname
Cidara Therapeutics Inc
Sektor
Branche
Telefon
858-752-6170
Adresse
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Vergleichen Sie CDTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
221.03 | 6.95B | 302.00K | -117.10M | -129.13M | -11.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-11-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-17 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-10-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-10 | Eingeleitet | JP Morgan | Overweight |
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-12 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-01-27 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2024-12-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-11-08 | Eingeleitet | Guggenheim | Buy |
| 2024-08-14 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-09-22 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | Eingeleitet | Aegis Capital | Buy |
| 2019-09-04 | Hochstufung | Wedbush | Neutral → Outperform |
| 2018-07-26 | Eingeleitet | Citigroup | Buy |
| 2017-04-21 | Eingeleitet | Raymond James | Strong Buy |
| 2017-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2017-04-12 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-04-11 | Fortgesetzt | Wedbush | Outperform |
| 2017-02-22 | Bestätigt | H.C. Wainwright | Buy |
| 2017-02-22 | Hochstufung | WBB Securities | Sell → Hold |
| 2016-12-21 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-12-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-09-23 | Herabstufung | WBB Securities | Hold → Sell |
| 2015-10-09 | Hochstufung | WBB Securities | Sell → Hold |
| 2015-05-11 | Eingeleitet | Jefferies | Buy |
| 2015-05-11 | Eingeleitet | Leerink Partners | Outperform |
| 2015-05-11 | Eingeleitet | Needham | Buy |
| 2015-05-11 | Eingeleitet | Wedbush | Outperform |
| 2015-04-23 | Eingeleitet | WBB Securities | Sell |
Alle ansehen
Cidara Therapeutics Inc Aktie (CDTX) Neueste Nachrichten
Top Biotech Stocks To Watch NowJanuary 2nd - MarketBeat
Cidara Therapeutics (CDTX) rockets 722% in 2025 on Merck $9.2-billion merger - MSN
Cidara Therapeutics (CDTX) Rockets 722% in 2025 on Merck $9.2-Billion Merger - Insider Monkey
Meet the 10 Market Stars Behind Millionaire-Making in 2025 - Insider Monkey
Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock? - Yahoo Finance
12 Overlooked Stocks That Delivered Massive Gains In 2025 - RTTNews
Best Biotech Stocks To Follow NowDecember 28th - MarketBeat
Biotech Stocks To ConsiderDecember 27th - MarketBeat
New Highs: Why Cidara Therapeutics Inc stock appeals to analystsWeekly Profit Recap & Daily Profit Focused Stock Screening - moha.gov.vn
Cidara: Merck's Acquisition Based On CD388 Flu Prevention Potential (NASDAQ:CDTX) - Seeking Alpha
Best Biotech Stocks Worth WatchingDecember 18th - MarketBeat
Merck Stock (MRK) News and Forecasts: FDA Fast-Track Vouchers, TrumpRx Pricing Deal, and Cidara Acquisition in Focus Ahead of the Next Market Session - ts2.tech
Understanding Momentum Shifts in (CDTX) - Stock Traders Daily
Top Biotech Stocks To Add to Your WatchlistDecember 20th - MarketBeat
Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat
RedChip Companies Congratulates Former Client Cidara Therapeutics on Its $9.2 Billion Acquisition by Merck - Siskiyou Daily News
Top 10 healthcare stocks according to YTD performance, as the sector holds steady - Seeking Alpha
Market Review: Will Cidara Therapeutics Inc stock recover faster than marketEarnings Risk Summary & Smart Swing Trading Techniques - moha.gov.vn
What dividend safety score for Cidara Therapeutics Inc. stockMarket Capitalization Trends & Minimal Capital Appreciation - Bollywood Helpline
Best Biotech Stocks To Watch NowDecember 16th - MarketBeat
Energy Moves: What market sentiment indicators show for Cidara Therapeutics Inc. (20D0) stockFed Meeting & AI Powered Buy/Sell Recommendations - moha.gov.vn
Why Cidara Therapeutics Inc. stock attracts high net worth investors - ulpravda.ru
Is Cidara Therapeutics Inc. stock a top momentum play2025 Valuation Update & Verified Technical Trade Signals - ulpravda.ru
Will Cidara Therapeutics Inc. stock reach all time highs in 2025Weekly Investment Recap & Comprehensive Market Scan Reports - Улправда
Merck, Cidara Therapeutics see US FTC grant early termination for $9.2bn deal - MLex
Merck, Cidara Therapeutics granted early termination by US FTC - MLex
Why Cidara Therapeutics Inc. stock appeals to analystsJuly 2025 Patterns & Expert Approved Momentum Ideas - DonanımHaber
What market sentiment indicators show for Cidara Therapeutics Inc. (20D0) stock2025 Momentum Check & Fast Momentum Entry Tips - Улправда
Sectors Review: Why Cidara Therapeutics Inc. stock attracts high net worth investorsQuarterly Trade Review & Weekly Setup with ROI Potential - Улправда
Halper Sadeh LLC Encourages EB, KPLT, WBD, CDTX Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Cidara Therapeutics (CDTX): Assessing Valuation After a 200% Three‑Month Share Price Surge - Yahoo Finance
Shane Ward Sells 9,959 Shares of Cidara Therapeutics (NASDAQ:CDTX) Stock - MarketBeat
(CDTX) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Cidara Therapeutics, Inc. $CDTX Shares Sold by BVF Inc. IL - MarketBeat
Bain Capital Life Sciences Investors LLC Purchases 1,797,600 Shares of Cidara Therapeutics, Inc. $CDTX - MarketBeat
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Cidara therapeutics COO Ward sells $2.19 million in stock By Investing.com - Investing.com Canada
Cidara therapeutics COO Ward sells $2.19 million in stock - Investing.com
CEO Stein Surrenders 2,285 Of Cidara Therapeutics Inc [CDTX] - TradingView — Track All Markets
Cidara Therapeutics’ Earnings Call Highlights CD388 Progress - MSN
Marshall Wace LLP Buys New Stake in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Analysts Shift to Hold as Cidara’s (CDTX) Recent Acquisition Deal Caps Upside - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Velan Capital Investment Management LP Makes New Investment in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Stempoint Capital LP Takes Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump - The Motley Fool
Vivo Capital LLC Boosts Stock Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Resolute Capital Asset Partners LLC Makes New $1.33 Million Investment in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Finanzdaten der Cidara Therapeutics Inc-Aktie (CDTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cidara Therapeutics Inc-Aktie (CDTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ward Shane | COO & CLO |
Dec 10 '25 |
Sale |
220.08 |
9,959 |
2,191,747 |
25,033 |
| Davarpanah Nicole Negar | Chief Medical Officer |
Sep 11 '25 |
Sale |
62.86 |
474 |
29,797 |
31,418 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Jun 26 '25 |
Buy |
44.00 |
2,272,727 |
99,999,988 |
3,365,523 |
| Mineo Chrysa | Director |
Jun 02 '25 |
Buy |
21.71 |
2,270 |
49,281 |
2,270 |
| Mineo Chrysa | Director |
Jun 03 '25 |
Buy |
23.44 |
1,050 |
24,614 |
3,320 |
| Ward Shane | COO & CLO |
Mar 11 '25 |
Sale |
21.96 |
1,664 |
36,542 |
14,674 |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER |
Mar 11 '25 |
Sale |
21.96 |
1,773 |
38,940 |
16,215 |
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):